J.D. Barker's FLATLINERS: RESURRECTION Complete and Expected to Generate Major Bidding War
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- International bestselling author J.D. Barker has completed FLATLINERS: RESURRECTION (working title), his highly anticipated novel reboot of the iconic 'Flatliners' franchise, and the project is now heading to publishers with industry insiders predicting one of the largest bidding wars of the year.
The completion of FLATLINERS: RESURRECTION marks a significant milestone for the franchise, which has captivated audiences since the original 1990 film exploring near-death experiences and the consequences of tampering with the boundaries between life and death.
'The phones haven't stopped ringing since this project was announced last year,' said Joel Gotler of Intellectual Property Group, who manages film, television, and domestic publishing rights in collaboration with Danny Baror at Baror International, Inc. 'I'm thrilled to finally take it out. Barker has crafted one hell of a tale. Not only does it hold true to the original, it also takes this in a very fresh and timely direction.'
Barker, renowned for his gripping suspense novels including DRACUL (Putnam), THE FOURTH MONKEY (HarperCollins), and SOMETHING I KEEP UPSTAIRS (Hampton Creek Press), wrote the novel with neuropsychologist turned co-author, Christine Daigle, under complete secrecy, sharing pages with no one until the manuscript was finished.
'We kept this one close to the vest,' Barker explained. 'I didn't want to risk a leak. The concept of 'Flatliners' has always fascinated me, and I wanted to ensure fans experienced this story exactly as intended - without any preconceptions or spoilers.'
FLATLINERS: RESURRECTION promises to delve deeper into the psychological and supernatural elements that made the original concept compelling, while introducing contemporary themes that resonate with today's audiences.
The original 'Flatliners' property, based on the screenplay by Peter Filardi, has maintained cultural relevance since its 1990 debut, with a 2017 film remake continuing to explore the franchise's central themes of mortality, consequences, and the unknown.
About J.D. Barker: Hampton Creek Press's J.D. Barker is the international bestselling author of numerous novels, including DRACUL and the wildly popular 4MK thriller series. His work has been translated into two dozen languages and optioned for both film and television. He regularly collaborates with James Patterson.
Contact: Film, Television, and Domestic Print rights are managed by Joel Gotler of Intellectual Property Group, 12400 Wilshire Blvd. Suite 500 Los Angeles, CA 90025, 310-402-5152. Foreign Print rights are managed by Danny Baror of Baror International, Inc., P.O. Box 868, Armonk, NY 10504
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs
According to Gallup, 71% of middle-income Americans are invested in the stock market, and they've watched their fortunes rise and fall repeatedly during the volatile period since President Donald Trump announced his trade tariffs on April 2. But as the official start of summer approaches, those who resisted the urge to panic-sell during the frightening declines have largely seen their discipline pay off. Check Out: Read Next: It's impossible to gauge what the average middle-class investor might have gained or lost because the concept is a construct, regardless of the investor's socioeconomic class. Even if it were possible to put a dollar amount on the mean middle-class earner's stock investments, that would ignore critical variables like that investor's: Type, size and number of stock or fund holdings Portfolio makeup Portfolio diversity Degree of leverage from options trading or margin borrowing Trade frequency Fees and expenses Discover More: For context on just how differently two otherwise similar middle-class investors can perform, consider that Warner Bros Discovery Inc. (WBD) cratered on April 2 and retained a 24% overall loss through June 10. Conversely, Palantir Technologies Inc. (PLTR) has been one of the top performers in the post-tariff era, adding most of its 74% year-to-date gains since April 2. Two middle-class stock pickers with identical incomes and backgrounds who rolled the anti-diversification dice by purchasing identical amounts in either stock on April 1 would have had radically different outcomes between then and mid-June. A more reliable metric might be the major indices that so many middle-class households invest in through their 401(k)s, IRAs, index funds and ETFs. Between April 2 and June 10: The S&P 500, the benchmark index for the U.S. stock market, gained 6.16%. The Dow Jones Industrial Average, which tracks the blue chips, gained 1.31%. The tech-heavy and more volatile Nasdaq gained 11.57%. The FTSE All Cap Index, which includes much of the global stock market with 10,000 small-, mid- and large-cap companies in both developed and emerging markets, gained 7.22%. The average among all four is 6.57%, which is roughly what typical middle-class earners might have gained since April 2 if they followed the conventional advice of diversifying their portfolios with a blend of blue chips, growth stocks and foreign equities, and holding their positions regardless of market behavior. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 Clever Ways To Save Money That Actually Work in 2025 7 Tax Loopholes the Rich Use To Pay Less and Build More Wealth This article originally appeared on How Much the Average Middle-Class American Has Gained in the Stock Market Since Trump Announced His Tariffs
Yahoo
13 minutes ago
- Yahoo
Watson Didn't Get Canceled, But It Suffered A Fate That Has Me Upset
When you buy through links on our articles, Future and its syndication partners may earn a commission. Even though CBS canceled a chunk of shows this year, there are still prime titles to look forward to for the 2025-26 season. That includes plenty of returning shows. Watson, the Morris Chestnut-led medical drama is among the series that managed to avoid the axe this spring amid the 2025 TV schedule and, as a fan, I'm very happy about that. However, what I'm not so pleased about is an update regarding when new episodes of the show will debut. CBS' schedule for next season reveals that Watson will not be back this fall and will instead be held for midseason in 2026. The show will still air on Sundays, but it will take over The Equalizer's slot at 10 p.m. ET, along with new Yellowstone spinoff Y: Marshals following Tracker. The wait is going to be excruciating for me, especially since the mystery series' first season ended with a major twist that saw the titular doctor murder enemy and Sherlock Holmes' killer James Moriarty. While speaking with Deadline, CBS Entertainment President Amy Reisenbach said she was still fairly confident the show will do well in its new timeslot, considering what it's being paired with: I'm fairly confident in Tracker and Y: Marshals being very, very big lead-ins for Watson. Watson does really, really well for us on streaming as well. So we expect that viewers who might not catch it at 10 o'clock will catch on streaming because it's had such a loyal fan base over on Paramount+. We think it's the best of both worlds. Despite the exec's confidence, I'm still not all that enthused about having to wait so long for new episodes. Sure, I understand the logic of holding the show as, during a given TV season, there are instances in which a show must be held for scheduling reasons. But having to wait until 2026 to see more of John Watson's story is just frustrating for me as a viewer. From a business standpoint, though, Reisenbach and co. are looking to ensure that interest in the show remains, and that method involves Paramount+ subscription holders: We'll definitely be pushing viewers to binge it on Paramount+ in the meantime. But there truly was a lack of room on the schedule. You look at that schedule, there's no other real logical place for it. Season 1 contains 13 episodes, and an official count has yet to be revealed for the second season. Based on past instances of midseason placings, I think it's possible that Watson could receive 18 episodes for Season 2, depending on when it's scheduled to premiere and how many breaks it has. For example, The Rookie and Will Trent on ABC will once again be airing midseason, and both shows and both put out 18 installments this year. Of course, this is a different network we're dealing with for Morris Chestnut's show. Paramount Plus: from $7.99 a month/$79.99 a yearStream Watson on Paramount+ by grabbing the Essential plan. Or go ad-free and receive double the catalog with Showtime through the Premium plan, which starts from $12.99 per month. Also, get 12 months for the price of 10 with the annual Deal It was quite gutsy for the Craig Sweeny-created show to go out with that killer finale. On top of the big Moriarty twist, twins Adam and Stephens Croft were on the brink of death due to a targeted virus but, as per usual, the team -- although down two people -- was able to save them both. Season 2 will more than likely follow up on the traumatic experience that the Crofts went through and the aftermath of Moriarty's death. As some who's really into Watson, I'm hoping the wait for new episodes will be worth it. At the very least, though, I suppose that I should just be grateful that Watson is returning at all, given the others shows that met their demises this spring. This time of year can be brutal for avid TV fans, and I'm glad one of my favorite shows is still on the docket.
Yahoo
13 minutes ago
- Yahoo
CBS' Watson Is Popular, But There's Another Sherlock Holmes TV Show That's Been A Quiet Success, And I Hope More People Start Watching It
When you buy through links on our articles, Future and its syndication partners may earn a commission. Earlier this year, Watson debuted on the 2025 TV schedule, giving CBS another hit Sherlock Holmes adaptation following Elementary's seven-season run in the 2010s. The Morris Chestnut-led medical drama was renewed for a second season back in March, though it won't premiere until 2026. While it's great that Watson has performed well for CBS, there's another TV show adapting the mythology centered around Sir Arthur Conan Doyle's famed detective that's been a quiet success in recent months, and I hope this leads to even more people watching it. Sherlock & Daughter premiered on The CW stateside on April 16, and it concluded its eight-episode first season earlier this week. But even before the Season 1 finale aired, the David Thewlis and Blu Hunt-led series was a standout on both the TV network and on the streaming front. Variety reports that following the show becoming available to stream with a Max subscription last week, it hit the #4 spot on the platform's top 10. Additionally, this past week also saw Sherlock & Daughter scoring its highest ratings of its debut season, growing almost 20% since its premiere. It ranks as The CW's number one scripted series on linear, i.e. traditional television, and number two series on digital. The report also mentions that Sherlock & Daughter airs on the SBS network in Australia, and its total audience increased an average of 150% across its first four episodes. It seems safe to say that this series classifies as a TV sleeper hit. I've been enjoying Sherlock & Daughter since it first arrived and hope even more people check it out in the weeks ahead now that Season 1 can be viewed in its entirety. Max: Save Up To $41 On Annual PlansIf you're eager to check out many of the other TV shows and movies on Max beyond Sherlock & Daughter, sign up for its annual plan, with up to 16% off its choice of three plans. Alternatively, its cheapest plan starts from $9.99 a month. You could also get Max as a part of the bundle with Disney Plus and Hulu, though, starting from $16.99 a Deal Set in 1896, the series follows David Thewlis' Sherlock Holmes meeting Blu Hunt's Amelia Rojas, a young Native American woman from California who claims to be the detective's daughter. While Sherlock is initially distrustful of Amelia's claim, the two soon start working together when they learn that the recent murder of Amelia's mother is tied to the conspiracy involving the Red Thread criminal syndicate, which has kidnapped Dr. John Watson and Mrs. Hudson to prevent Sherlock from interfering in their affairs. Sherlock & Daughter is the second Sherlock Holmes adaptation that Thewlis has starred in, as he previously played the villainous police superintendent Grail in the Netflix subscription-exclusive movie Enola Holmes 2, which starred Millie Bobby Brown as the title character and Henry Cavill as Sherlock. Blunt is arguably best known for playing Danielle Moonstar, a.k.a. Mirage, in The New Mutants, as well as appeared in the TV shows The Originals and Another Life. This series' other main cast members include Fiona Glascott, Joe Kloeck, Aidan McAdrle and Dougray Scott. There's no word yet on if Sherlock & Daughter will return for Season 2, though I'd like to think that these streaming and linear stats boost the chances of another batch of episodes being order. For now, we can look forward to yet another Sherlock Holmes TV show coming soon, as Guy Ritchie's Young Sherlock starring Hero Fiennes Tiffin is being put together for Prime Video.
